Role of E2F and ERK1/2 in STI571-mediated smooth muscle cell growth arrest and cyclin A transcriptional repression
- 14 May 2004
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 317 (4) , 972-979
- https://doi.org/10.1016/j.bbrc.2004.03.143
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Distinct Regulation of Mitogen-activated Protein Kinases and p27Kip1 in Smooth Muscle Cells from Different Vascular BedsPublished by Elsevier ,2003
- Growth inhibition and modulation of kinase pathways of small cell lung cancer cell lines by the novel tyrosine kinase inhibitor STI 571Oncogene, 2000
- Role of c-fos and E2F in the induction of cyclin A transcription and vascular smooth muscle cell proliferation.Journal of Clinical Investigation, 1998
- Ischemia-Induced Transplant Arteriosclerosis in the RatArteriosclerosis, Thrombosis, and Vascular Biology, 1996
- Tyrosine kinase inhibitor suppresses coronary arteriosclerotic changes and vasospastic responses induced by chronic treatment with interleukin-1 beta in pigs in vivo.Journal of Clinical Investigation, 1995
- Protein tyrosine kinase inhibitors inhibit chemotaxis of vascular smooth muscle cells.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Growth factors in pathogenesis of coronary arterial restenosisThe American Journal of Cardiology, 1991
- PDGF ligand and receptor gene expression during repair of arterial injury.The Journal of cell biology, 1990
- Platelet‐derived growth factor regulates actin isoform expression and growth factor regulates actin isoform expression and growth state in cultured rat aortic smooth muscle cellsJournal of Cellular Physiology, 1990
- The biology of platelet-derived growth factorCell, 1986